Ledipasvir/Sofosbuvir Safety+Tolerability With&Without Ribavirin in Chronic HCV Infection

30.11.2015

HEPATOLOGY Podcast

0:00

10:41

Note: Published earlier in 2015. Drs. Stephen A. Harrison and Saleh A. Alqahtani discuss the paper: Safety and Tolerability of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: Analysis of Phase III ION Trials.

Weitere Episoden von „HEPATOLOGY Podcast“

The Severity Of Steatosis Influences Liver Stiffness Measurement In Patients With NAFLD
12.1.2016
7:24
Drs. Stephen A. Harrison and Salvatore Petta discuss the paper: The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease from the November 2015 issue of HEPATOLOGY.
Ledipasvir/Sofosbuvir Safety+Tolerability With&Without Ribavirin in Chronic HCV Infection
30.11.2015
10:41
Note: Published earlier in 2015. Drs. Stephen A. Harrison and Saleh A. Alqahtani discuss the paper: Safety and Tolerability of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: Analysis of Phase III ION Trials.
Verpasse keine Episode von “HEPATOLOGY Podcast” und abonniere ihn in der kostenlosen GetPodcast App.
Association of NAFLD with Subclinical Myocardial Remodeling and Dysfunction
17.9.2015
11:17
Drs. Stephen A. Harrison and Lisa B. VanWagner discuss the paper: Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study.
The Role of Hepatic Resection in Liver Cancer
10.9.2015
11:04
Drs. Stephen A. Harrison and Sasan Roayaie discuss the paper: The Role of Hepatic Resection in the Treatment of Hepatocellular Cancer.
Ledipasvir/Sofosbuvir Safety+Tolerability With&Without Ribavirin in Chronic HCV Infection
30.7.2015
10:41
Drs. Stephen A. Harrison and Saleh A. Alqahtani discuss the paper: Safety and Tolerability of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: Analysis of Phase III ION Trials.
The Impact of Phlebotomy in Nonalcoholic Fatty Liver Disease
23.6.2015
11:25
Drs. Stephen A. Harrison and Leon A. Adams discuss the paper: The Impact of Phlebotomy in Nonalcoholic Fatty Liver Disease: A Prospective, Randomized, Controlled Trial.
Portal Hypertension and the Outcome of Surgery for HCC
23.1.2015
11:47
Drs. Stephen A. Harrison and Annalisa Berzigotti discuss the paper: Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta-analysis from the Februrary issue of HEPATOLOGY.
Concordance Of Sustained Virological Response With Sofosbuvir - Containing Regimens For HCV
15.1.2015
7:02
Drs. Stephen A. Harrison and Eric M. Yoshida discuss the paper: Concordance of sustained virological response 4, 12, and 24 weeks post-treatment with sofosbuvir-containing regimens for hepatitis C virus from the January issue of HEPATOLOGY.
Prioritizing HCC Patients -- Results Of The UNOS National Geographic Experiment
15.1.2015
6:29
Drs. Stephen A. Harrison and Karim J. Hazalun discuss the paper: Standing the test of time: Outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment from the December issue of HEPATOLOGY.
Enhanced MRI Prognosis Of Early Early Stage HCC
15.1.2015
10:54
Stephen A. Harrison, MD and Taro Yamashita, MD, PhD, discuss Gd-EOB-DTPA-enhanced MRI and Alpha-fetoprotein Predict Prognosis of Early Early Stage HCC.

Weitere Episoden

Hol dir die ganze Welt der Podcasts mit der kostenlosen GetPodcast App.

Abonniere alle deine Lieblingspodcasts, höre Episoden auch offline und erhalte passende Empfehlungen für Podcasts, die dich wirklich interessieren.

Ledipasvir/Sofosbuvir Safety+Tolerability With&Without Ribavirin in Chronic HCV Infection

HEPATOLOGY Podcast

Weitere Episoden von „HEPATOLOGY Podcast“

The Severity Of Steatosis Influences Liver Stiffness Measurement In Patients With NAFLD

Ledipasvir/Sofosbuvir Safety+Tolerability With&Without Ribavirin in Chronic HCV Infection

Association of NAFLD with Subclinical Myocardial Remodeling and Dysfunction

The Role of Hepatic Resection in Liver Cancer

Ledipasvir/Sofosbuvir Safety+Tolerability With&Without Ribavirin in Chronic HCV Infection

The Impact of Phlebotomy in Nonalcoholic Fatty Liver Disease

Portal Hypertension and the Outcome of Surgery for HCC

Concordance Of Sustained Virological Response With Sofosbuvir - Containing Regimens For HCV

Prioritizing HCC Patients -- Results Of The UNOS National Geographic Experiment

Enhanced MRI Prognosis Of Early Early Stage HCC